WAY-297174

CAS No. 442571-27-9

WAY-297174( —— )

Catalog No. M35318 CAS No. 442571-27-9

WAY-297174 is a human protein kinase CK2 inhibitor with IC50 of > 33 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 149 In Stock
5MG 158 In Stock
10MG 229 In Stock
25MG 378 In Stock
50MG 556 In Stock
100MG 793 In Stock
200MG Get Quote In Stock
500MG 1609 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-297174
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-297174 is a human protein kinase CK2 inhibitor with IC50 of > 33 μM.
  • Description
    CK2-IN-8 (compound 5c) is a CK2 inhibitor with IC50 >33 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    Casein Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    442571-27-9
  • Formula Weight
    268.36
  • Molecular Formula
    C11H12N2O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(C(C(O)=O)C)C1=C2C(SC(C)=C2C)=NC=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Golub AG, et al. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2. Eur J Med Chem. 2011 Mar;46(3):870-6.?
molnova catalog
related products
  • Casein kinase 1δ-IN-...

    Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.

  • Longdaysin

    Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).

  • CK2α-IN-1

    CK2α-IN-1 is a selective non-ATP-competitive CK2α inhibitor with an IC50 of 7.0 μM and a Ki of 1.6 μM.CK2α-IN-1 exhibits potential anticancer activity and can be used in cancer research.